Walgreens, Prime Therapeutics strike partnership: 5 things to know

Walgreens is partnering with St. Paul, Minn.-based Prime Therapeutics, a pharmacy benefit manager owned by 14 Blue Cross and Blue Shield health plans.

Advertisement

Here are five things to know about the partnership.

1. The partnership includes a new retail pharmacy network agreement and the combination of the companies’ central specialty pharmacy and mail service businesses.

2. Under the partnership, Walgreens will be the core participant in Prime’s national preferred pharmacy network, beginning Jan. 1., both companies said. They said Prime’s 22 million members may also benefit from personalized pharmacy services and possible reduced costs when filling their prescriptions at Walgreens.

3. The combined central specialty and mail services company will be governed by a separate board of directors and executive team, which will be selected by Walgreens and Prime.

4. The transaction is expected to close in the first half of calendar 2017.

5. Financial terms of the deal weren’t disclosed.

 

More articles about healthcare transactions and valuations:
Eastern Connecticut Health Network sale delayed
Wellmont-MSHA merger application moves forward
HealthSouth, Tidelands Health announce joint venture

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.